The national supply of blood is dropping to dangerously low levels nationwide; the Veterans Health Administration will offer gender-affirming surgeries to transgender veterans; several vulnerable states are spotlighted amid the spread of the more transmissible delta COVID-19 variant.
As the national supply of blood dropped to the critical “red” level this month, indicating dangerously low supply at blood centers across the United States, elective surgeries and some patient care have been delayed, with blood products being reserved for patients most in need. As reported by ABC News, the Red Cross, which supplies 40% of the nation's blood supply, said that approximately 7000 units of platelets and 36,000 units of red blood cells are needed daily. With the pandemic and a rise in violent crime noted to have put an additional strain on the blood supply, demand for blood has risen by 10% in hospitals with trauma centers and by more than 5 times in facilities that provide transfusions, in comparison with 2019.
Veterans Affairs officials have announced plans to offer gender-affirming surgeries for transgender veterans for the first time. According to Military Times, estimates from the National Center for Transgender Equality indicate that there are more than 134,000 transgender veterans and 15,000 currently serving in the United States, of which 4000 veterans were estimated to be interested in the surgeries. The LGBT health program from the Veterans Health Administration is also to be renamed to the LGBTQ+ program to reflect new standards of inclusiveness in the armed forces.
With the novel delta variant suggested to become the dominant strain of COVID-19 in the United States, an article by CNN spotlighted several states whose vaccination rates may place them at an increased risk. Currently, 45.1% of the US population is fully vaccinated against COVID-19, although this rate decreases to less than 35% in southern states such as Alabama, Louisiana, and Mississippi. Associated with being more transmissible than the alpha variant first identified in the United Kingdom, new research indicates that cases of the delta variant are quickly rising in counties with fewer vaccinated residents.
Unique Psychological Burden of Fear of Progression Seen in MG
August 6th 2025Fear of progression is common among patients living with chronic diseases, but the degree to which it interferes with patient outcomes, including treatment adherence, deserves further investigation, study authors note.
Read More
Taletrectinib Recommended in NCCN Guidelines for ROS1-Positive NSCLC
July 31st 2025Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).
Read More